Pharmaceutics giant Pfizer has agreed to pay $60 million to US authorities in a compromise following bribe allegations.

US Bond Authority has accused Pfizer of bribing clerks in China, Italy, Russian and Eastern Europe in order to obtain contracts and sales, writing the payments off as expenses.